TWI676485B - Composition containing collagen peptide - Google Patents
Composition containing collagen peptide Download PDFInfo
- Publication number
- TWI676485B TWI676485B TW105101036A TW105101036A TWI676485B TW I676485 B TWI676485 B TW I676485B TW 105101036 A TW105101036 A TW 105101036A TW 105101036 A TW105101036 A TW 105101036A TW I676485 B TWI676485 B TW I676485B
- Authority
- TW
- Taiwan
- Prior art keywords
- pectin
- proteoglycan
- weight
- composition
- present
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 91
- 102000008186 Collagen Human genes 0.000 title claims abstract description 60
- 108010035532 Collagen Proteins 0.000 title claims abstract description 60
- 229920001436 collagen Polymers 0.000 title claims abstract description 60
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 57
- 239000001814 pectin Substances 0.000 claims abstract description 82
- 229920001277 pectin Polymers 0.000 claims abstract description 82
- 235000010987 pectin Nutrition 0.000 claims abstract description 82
- 108010067787 Proteoglycans Proteins 0.000 claims abstract description 72
- 102000016611 Proteoglycans Human genes 0.000 claims abstract description 72
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 23
- 238000000034 method Methods 0.000 claims description 29
- 239000004615 ingredient Substances 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 16
- 238000002156 mixing Methods 0.000 claims description 13
- 230000001537 neural effect Effects 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 7
- 230000003020 moisturizing effect Effects 0.000 claims description 7
- 238000011049 filling Methods 0.000 claims description 5
- 150000001412 amines Chemical class 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 230000003796 beauty Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- BCGWQEUPMDMJNV-UHFFFAOYSA-N imipramine Chemical compound C1CC2=CC=CC=C2N(CCCN(C)C)C2=CC=CC=C21 BCGWQEUPMDMJNV-UHFFFAOYSA-N 0.000 claims 2
- 239000002244 precipitate Substances 0.000 abstract description 36
- 230000015572 biosynthetic process Effects 0.000 abstract description 16
- 239000000284 extract Substances 0.000 description 27
- 210000003491 skin Anatomy 0.000 description 21
- 235000013361 beverage Nutrition 0.000 description 18
- 239000007864 aqueous solution Substances 0.000 description 15
- 230000000694 effects Effects 0.000 description 14
- 239000000796 flavoring agent Substances 0.000 description 13
- 235000019634 flavors Nutrition 0.000 description 13
- 235000013305 food Nutrition 0.000 description 12
- 241000196324 Embryophyta Species 0.000 description 11
- 238000001556 precipitation Methods 0.000 description 11
- 238000011156 evaluation Methods 0.000 description 10
- 239000002994 raw material Substances 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 9
- 239000000463 material Substances 0.000 description 8
- 229940106189 ceramide Drugs 0.000 description 7
- 238000000746 purification Methods 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 235000013399 edible fruits Nutrition 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 241000972773 Aulopiformes Species 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- 230000004520 agglutination Effects 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- 229920000159 gelatin Polymers 0.000 description 5
- 235000019515 salmon Nutrition 0.000 description 5
- 241000251468 Actinopterygii Species 0.000 description 4
- 241000167854 Bourreria succulenta Species 0.000 description 4
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 4
- 235000004431 Linum usitatissimum Nutrition 0.000 description 4
- 240000006240 Linum usitatissimum Species 0.000 description 4
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 4
- 240000007594 Oryza sativa Species 0.000 description 4
- 235000007164 Oryza sativa Nutrition 0.000 description 4
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 4
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 4
- 235000019693 cherries Nutrition 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 235000019688 fish Nutrition 0.000 description 4
- 235000004426 flaxseed Nutrition 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 4
- 239000000419 plant extract Substances 0.000 description 4
- 235000009566 rice Nutrition 0.000 description 4
- 239000013049 sediment Substances 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 3
- 102100036601 Aggrecan core protein Human genes 0.000 description 3
- 108010067219 Aggrecans Proteins 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 3
- 240000000560 Citrus x paradisi Species 0.000 description 3
- 206010013786 Dry skin Diseases 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 150000001783 ceramides Chemical class 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 230000037336 dry skin Effects 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- -1 for example Substances 0.000 description 3
- 238000011990 functional testing Methods 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 229960002442 glucosamine Drugs 0.000 description 3
- 210000002184 nasal cartilage Anatomy 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- 235000013616 tea Nutrition 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 244000099147 Ananas comosus Species 0.000 description 2
- 235000007119 Ananas comosus Nutrition 0.000 description 2
- 235000016068 Berberis vulgaris Nutrition 0.000 description 2
- 241000335053 Beta vulgaris Species 0.000 description 2
- 241000207199 Citrus Species 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241000237852 Mollusca Species 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000013330 chicken meat Nutrition 0.000 description 2
- 235000020971 citrus fruits Nutrition 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 238000005227 gel permeation chromatography Methods 0.000 description 2
- 238000001879 gelation Methods 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 238000010979 pH adjustment Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- HGXBRUKMWQGOIE-AFHBHXEDSA-N (+)-pinoresinol Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@@H]3[C@@H]([C@H](OC3)C=3C=C(OC)C(O)=CC=3)CO2)=C1 HGXBRUKMWQGOIE-AFHBHXEDSA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N 2,3,4,5-tetrahydroxypentanal Chemical compound OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 1
- HOMYIYLRRDTKAA-UHFFFAOYSA-N 2-hydroxy-N-[3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadeca-4,8-dien-2-yl]hexadecanamide Chemical compound CCCCCCCCCCCCCCC(O)C(=O)NC(C(O)C=CCCC=CCCCCCCCCC)COC1OC(CO)C(O)C(O)C1O HOMYIYLRRDTKAA-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- FNEHAOQZWPHONV-UHFFFAOYSA-N 9h-carbazole;sulfuric acid Chemical compound OS(O)(=O)=O.C1=CC=C2C3=CC=CC=C3NC2=C1 FNEHAOQZWPHONV-UHFFFAOYSA-N 0.000 description 1
- 101150079978 AGRN gene Proteins 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 244000298697 Actinidia deliciosa Species 0.000 description 1
- 102100040026 Agrin Human genes 0.000 description 1
- 108700019743 Agrin Proteins 0.000 description 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 1
- 240000001592 Amaranthus caudatus Species 0.000 description 1
- 241000238421 Arthropoda Species 0.000 description 1
- 238000012371 Aseptic Filling Methods 0.000 description 1
- 235000010082 Averrhoa carambola Nutrition 0.000 description 1
- 240000006063 Averrhoa carambola Species 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 240000005343 Azadirachta indica Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102100036597 Basement membrane-specific heparan sulfate proteoglycan core protein Human genes 0.000 description 1
- 108010085074 Brevican Proteins 0.000 description 1
- 102100032312 Brevican core protein Human genes 0.000 description 1
- 235000002567 Capsicum annuum Nutrition 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 101710132601 Capsid protein Proteins 0.000 description 1
- 102000005600 Cathepsins Human genes 0.000 description 1
- 108010084457 Cathepsins Proteins 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 235000002787 Coriandrum sativum Nutrition 0.000 description 1
- 244000018436 Coriandrum sativum Species 0.000 description 1
- 244000019459 Cynara cardunculus Species 0.000 description 1
- 235000019106 Cynara scolymus Nutrition 0.000 description 1
- AEMOLEFTQBMNLQ-DTEWXJGMSA-N D-Galacturonic acid Natural products O[C@@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-DTEWXJGMSA-N 0.000 description 1
- 102000004237 Decorin Human genes 0.000 description 1
- 108090000738 Decorin Proteins 0.000 description 1
- 229920000045 Dermatan sulfate Polymers 0.000 description 1
- 102000007623 Dystroglycans Human genes 0.000 description 1
- 108010071885 Dystroglycans Proteins 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- 241000208688 Eucommia Species 0.000 description 1
- 241000555682 Forsythia x intermedia Species 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 235000017048 Garcinia mangostana Nutrition 0.000 description 1
- 240000006053 Garcinia mangostana Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 239000009141 Houttuynia cordata plant extract Substances 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 241000218652 Larix Species 0.000 description 1
- 235000005590 Larix decidua Nutrition 0.000 description 1
- 235000000421 Lepidium meyenii Nutrition 0.000 description 1
- 240000000759 Lepidium meyenii Species 0.000 description 1
- 235000019510 Long pepper Nutrition 0.000 description 1
- 235000001387 Lonicera caerulea Nutrition 0.000 description 1
- 240000002734 Lonicera caerulea Species 0.000 description 1
- 244000070406 Malus silvestris Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- 235000013500 Melia azadirachta Nutrition 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 102000005348 Neuraminidase Human genes 0.000 description 1
- 108010006232 Neuraminidase Proteins 0.000 description 1
- 108010043296 Neurocan Proteins 0.000 description 1
- 102100030466 Neurocan core protein Human genes 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 241000238413 Octopus Species 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 240000003455 Piper longum Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 244000128206 Pyracantha coccinea Species 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 244000019194 Sorbus aucuparia Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 240000007313 Tilia cordata Species 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 238000011481 absorbance measurement Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 235000014104 aloe vera supplement Nutrition 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 235000012735 amaranth Nutrition 0.000 description 1
- 239000004178 amaranth Substances 0.000 description 1
- 150000001409 amidines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 235000016520 artichoke thistle Nutrition 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- AEMOLEFTQBMNLQ-UHFFFAOYSA-N beta-D-galactopyranuronic acid Natural products OC1OC(C(O)=O)C(O)C(O)C1O AEMOLEFTQBMNLQ-UHFFFAOYSA-N 0.000 description 1
- YIGARKIIFOHVPF-CNUVFPMCSA-N beta-D-glucosyl-N-(docosanoyl)sphingosine Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)N[C@H]([C@H](O)\C=C\CCCCCCCCCCCCC)CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YIGARKIIFOHVPF-CNUVFPMCSA-N 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 229940055416 blueberry extract Drugs 0.000 description 1
- 235000019216 blueberry extract Nutrition 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 239000001511 capsicum annuum Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 229940059958 centella asiatica extract Drugs 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 235000020230 cinnamon extract Nutrition 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229940029991 coriander extract Drugs 0.000 description 1
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 1
- 229940051593 dermatan sulfate Drugs 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 229940002508 ginger extract Drugs 0.000 description 1
- 235000020708 ginger extract Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000012902 lepidium meyenii Nutrition 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- DDOVBCWVTOHGCU-QMXMISKISA-N n-[(e,2s,3r)-3-hydroxy-1-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxynonadec-4-en-2-yl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@H]([C@H](O)\C=C\CCCCCCCCCCCCCC)CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O DDOVBCWVTOHGCU-QMXMISKISA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 108010049224 perlecan Proteins 0.000 description 1
- YHHSONZFOIEMCP-UHFFFAOYSA-O phosphocholine Chemical compound C[N+](C)(C)CCOP(O)(O)=O YHHSONZFOIEMCP-UHFFFAOYSA-O 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229950004354 phosphorylcholine Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229940106587 pine bark extract Drugs 0.000 description 1
- 235000020741 pine bark extract Nutrition 0.000 description 1
- OHOPKHNWLCMLSW-UHFFFAOYSA-N pinoresinol Natural products C1=C(O)C(OC)=CC(C2C3C(C(OC3)C=3C=C(CO)C(O)=CC=3)CO2)=C1 OHOPKHNWLCMLSW-UHFFFAOYSA-N 0.000 description 1
- 235000007221 pinoresinol Nutrition 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 229940124272 protein stabilizer Drugs 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229940108461 rennet Drugs 0.000 description 1
- 108010058314 rennet Proteins 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229940112950 sage extract Drugs 0.000 description 1
- 235000020752 sage extract Nutrition 0.000 description 1
- 235000006414 serbal de cazadores Nutrition 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 235000003687 soy isoflavones Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000001430 tilia cordata extract Substances 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 229960001322 trypsin Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- BURBOJZOZGMMQF-UHFFFAOYSA-N xanthoxylol Natural products C1=C(O)C(OC)=CC=C1C1C(COC2C=3C=C4OCOC4=CC=3)C2CO1 BURBOJZOZGMMQF-UHFFFAOYSA-N 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本發明之課題係提供一種抑制了凝集物或沉澱物之生成,且含有膠原蛋白肽、蛋白聚糖及神經醯胺之組成物。 An object of the present invention is to provide a composition which inhibits the formation of agglutinates or precipitates, and contains a collagen peptide, proteoglycan, and neuraminamine.
本發明之解決方式係於含有膠原蛋白肽、蛋白聚糖及神經醯胺之組成物中,添加果膠。 The solution of the present invention is to add pectin to a composition containing collagen peptides, proteoglycans, and neuraminamine.
Description
本發明係有關含有膠原蛋白肽之組成物。更詳細係有關含有膠原蛋白肽、蛋白聚糖、神經醯胺及果膠之組成物,以及抑制於含有膠原蛋白肽、蛋白聚糖及神經醯胺之組成物中凝集物或沉澱物之生成之方法。 The present invention relates to a composition containing a collagen peptide. In more detail, it is related to the composition containing collagen peptide, proteoglycan, neuraminamine and pectin, and the inhibition of the formation of agglutinates or precipitates in the composition containing collagen peptide, proteoglycan and neuraminamine method.
近年來,美容及防止肌膚老化等課題深受女性關注。由於膠原蛋白肽具有提高肌膚保溼性及彈性等美肌效果、改善血液流動性效果等各式各樣的功能,近來被使用於許多飲料、食品、化妝品中。另外,由於蛋白聚糖具有皮膚新陳代謝活性化功能,同時具有高保溼力,係一般消費者廣為習知的一種美肌成分,且被使用於各式各樣的商品中。進而,已知神經醯胺係具有保護皮膚作用及防止肌膚粗糙乾燥的效果。 In recent years, issues such as beauty and prevention of skin aging have attracted much attention from women. Collagen peptides have various functions such as improving skin moisturizing and elasticity, and improving blood fluidity. They have recently been used in many beverages, foods, and cosmetics. In addition, proteoglycan has skin metabolism activation function and high moisturizing power. It is a well-being ingredient that is widely known by ordinary consumers and is used in various products. Furthermore, it has been known that neural amines have the effect of protecting the skin and preventing the skin from being rough and dry.
目前已知膠原蛋白肽、蛋白聚糖及神經醯胺具有保溼與保護皮膚效果、改善肌膚鬆弛等與美容相關的效果。因此,多將該等成分摻混於食品、醫藥品及化妝品中。 Currently known collagen peptides, proteoglycans, and ceramides have cosmetic-related effects such as moisturizing and protecting the skin and improving skin relaxation. Therefore, these ingredients are often blended in foods, pharmaceuticals, and cosmetics.
含有膠原蛋白肽等具有功能成分之組成物,多使用於 飲料。因飲料係可利用膠囊與錠劑等以高濃度添加期望成份,且容易攝取,亦可藉由配合消費者喜好選擇香味成分、酸味料、甜味料等而提高商品價值。然而,相關含有膠原蛋白肽的組成物,存在生成凝集物與沉澱物的問題。目前已報告數種抑制組成物中凝集物與沉澱物生成之方法(專利文獻1及2)。 Contains functional ingredients such as collagen peptides, mostly used in Drink. Because beverages can use capsules and lozenges to add desired ingredients at high concentrations and are easy to ingest, they can also increase the value of products by choosing flavor ingredients, sour ingredients, sweeteners, etc. according to consumer preferences. However, the related composition containing collagen peptides has a problem of generating agglomerates and precipitates. Several methods have been reported for inhibiting the formation of aggregates and precipitates in the composition (Patent Documents 1 and 2).
[專利文獻1]專利第3416102號 [Patent Document 1] Patent No. 3416102
[專利文獻2]專利第5021909號 [Patent Document 2] Patent No. 5021909
含有膠原蛋白肽等成分之組成物生成凝集物與沉澱物,有時會損及該組成物之外觀。因該等外觀上的問題,擔憂會致使含有膠原蛋白肽等成分之組成物減低其商品形象與降低商品價值。 Compositions containing ingredients such as collagen peptides generate agglomerates and precipitates, which sometimes impair the appearance of the composition. Due to these appearance problems, there is a concern that a composition containing ingredients such as collagen peptides will reduce its product image and value.
本發明係以提供經抑制凝集物與沉澱物生成之組成物為課題。 The subject of the present invention is to provide a composition which inhibits the formation of agglomerates and precipitates.
本發明團隊為解決上述課題進行專心檢討後,發現含有膠原蛋白肽、蛋白聚糖、及神經醯胺之組成物中會有凝集物或沉澱物之生成,而該當凝集物或沉澱物之生成可藉 由添加果膠而抑制。 After intensive review by the team of the present invention in order to solve the above-mentioned problems, it was found that agglomerates or precipitates may be formed in a composition containing collagen peptides, proteoglycans, and neural cramines, and the formation of the agglomerates or precipitates may borrow Suppressed by the addition of pectin.
亦即,本發明係與下述內容有關,但並未限定於該等內容。 That is, the present invention relates to the following contents, but is not limited to these contents.
1).一種組成物,其係含有膠原蛋白肽、蛋白聚糖、神經醯胺及果膠。 1). A composition comprising a collagen peptide, proteoglycan, neuraminamide and pectin.
2).如1)之組成物,其係液狀。 2). The composition according to 1) is liquid.
3).如1)或2)之組成物,其中蛋白聚糖的含量為0.0001~0.05w/v%。 3). The composition according to 1) or 2), wherein the content of proteoglycan is 0.0001 to 0.05 w / v%.
4).如1)~3)中任一項之組成物,其中果膠的含量為0.05~0.8w/v%。 4). The composition according to any one of 1) to 3), wherein the content of pectin is 0.05 to 0.8 w / v%.
5).如1)~4)中任一項之組成物,其中蛋白聚糖的重量與果膠的重量之比率(蛋白聚糖重量:果膠重量)係1:1~1:800。 5). The composition according to any one of 1) to 4), wherein the ratio of the weight of proteoglycan to the weight of pectin (proteoglycan weight: pectin weight) is 1: 1 to 1: 800.
6).如1)~5)中任一項之組成物,其中膠原蛋白肽的含量為1.0~25w/v%。 6). The composition according to any one of 1) to 5), wherein the content of the collagen peptide is 1.0 to 25 w / v%.
7).如1)~6)中任一項之組成物,其中神經醯胺的含量為0.0001~0.1w/v%。 7). The composition according to any one of 1) to 6), wherein the content of neuraminamine is 0.0001 to 0.1 w / v%.
8).如2)~7)中任一項之組成物,其中pH係2.5~5.0。 8). The composition according to any one of 2) to 7), wherein the pH is 2.5 to 5.0.
9).如1)~8)中任一項之組成物,其係經口用。 9). The composition according to any one of 1) to 8), which is for oral use.
10).如1)~9)中任一項之組成物,其係美肌用。 10). The composition according to any one of 1) to 9), which is used for beauty.
11).一種方法,其特徵係抑制含膠原蛋白肽、蛋白聚糖及神經醯胺之組成物中,凝集物或沉澱物之生成之方法, 其係包含於該組成物中摻混果膠之步驟。 11) A method characterized by the method of inhibiting the formation of agglutinates or precipitates in a composition containing collagen peptides, proteoglycans and neural amines, It is a step of blending pectin into the composition.
12).如11)之方法,其中摻混果膠之量相對於組成物全量為0.05~0.8w/v%。 12). The method according to 11), wherein the amount of blended pectin is 0.05 to 0.8 w / v% relative to the total amount of the composition.
13).如11)或12)之方法,其中摻混果膠之量,係以使蛋白聚糖的重量與果膠的重量之比率(蛋白聚糖重量:果膠重量)成為1:1~1:800而進行摻混。 13) The method according to 11) or 12), wherein the amount of pectin is blended so that the ratio of the weight of proteoglycan to the weight of pectin (proteoglycan weight: pectin weight) becomes 1: 1 ~ The blending was performed at 1: 800.
14).如1)~10)中任一項之組成物,其係附註具有起因於膠原蛋白肽、蛋白聚糖、神經醯胺或果膠的效能之表示。 14). The composition according to any one of 1) to 10), which is an expression indicating that the effect is caused by collagen peptide, proteoglycan, neuraminamine, or pectin.
15).如14)之組成物,其中該表示係保溼、保護皮膚、防止肌膚乾燥、或改善肌膚鬆弛。 15). The composition according to 14), wherein the indication is to moisturize, protect the skin, prevent skin from drying out, or improve skin relaxation.
16).一種方法,其特徵係含膠原蛋白肽、蛋白聚糖、神經醯胺及果膠之組成物之製造方法,其係包含摻混含有膠原蛋白肽、蛋白聚糖、神經醯胺及果膠之原料之步驟,以及,對前述調合物進行殺菌、填充之步驟。 16) A method, characterized in that it is a method for manufacturing a composition containing collagen peptide, proteoglycan, neuraminamine and pectin, which comprises blending collagen peptide, proteoglycan, neuraminamine and pectin A step of the raw material of the gum, and a step of sterilizing and filling the aforementioned blend.
17).如16)之方法,其中果膠之摻混量相對於組成物全量為0.05~0.8w/v%。 17) The method according to 16), wherein the blending amount of pectin is 0.05 to 0.8 w / v% relative to the total amount of the composition.
18).如16)或17)之方法,其中果膠之摻混量,係以使蛋白聚糖的重量與果膠的重量之比率(蛋白聚糖重量:果膠重量)成為1:1~1:800而進行摻混。 18) The method according to 16) or 17), wherein the blending amount of pectin is such that the ratio of the weight of proteoglycan to the weight of pectin (proteoglycan weight: pectin weight) becomes 1: 1 ~ The blending was performed at 1: 800.
本發明係藉由於含有膠原蛋白肽、蛋白聚糖及神經醯胺之組成物中添加果膠,可抑制凝集物或沉澱物的生成。 In the present invention, the addition of pectin to a composition containing collagen peptides, proteoglycans, and neuraminamine can inhibit the formation of agglomerates or precipitates.
本發明中使用之膠原蛋白肽,可將膠原蛋白或明膠等改性膠原蛋白,利用酵素、酸、鹼等水解處理而得,但並未特別限制其由來與製法。 The collagen peptide used in the present invention can be obtained by modifying collagen, gelatin, or other modified collagen by hydrolyzing enzymes, acids, and alkalis, but the origin and production method are not particularly limited.
例如,作為原料的膠原蛋白或明膠,可為來自牛、豬、雞、魚等者,可使用該等之1種或2種以上作為原材料。 For example, as the raw material, collagen or gelatin may be derived from cattle, pigs, chickens, fish, or the like, and one or two or more of these may be used as the raw materials.
用於調製膠原蛋白肽的酵素,若為可切斷膠原蛋白或明膠之胜肽鍵結者為佳,例如可舉出膠原蛋白酶、木瓜酶、鳳梨酵素、奇異果酵素、無花果酵素、組織蛋白酶、胃蛋白酶、凝乳酶、胰蛋白酶及混合該等酵素之酵素製劑等。 Enzymes used for the preparation of collagen peptides are preferably those that can cut the bond of collagen or gelatin. For example, collagenase, papain, pineapple enzyme, kiwifruit enzyme, fig enzyme, cathepsin, Pepsin, rennet, trypsin, and enzyme preparations mixed with these enzymes.
酸可使用例如鹽酸、硫酸、硝酸等。鹼可使用例如氫氧化鈉、氫氧化鈣等。 As the acid, for example, hydrochloric acid, sulfuric acid, nitric acid and the like can be used. As the base, for example, sodium hydroxide, calcium hydroxide, and the like can be used.
本發明中可直接使用經水解之膠原蛋白肽的水溶液,亦可使用藉由乾燥等經粉末化者。另外,該當水溶液亦可將一般使用之經施以純化處理者,以水溶液及粉末等型態使用。即便以任一種型態使用該等物質,亦不會對本發明的效果造成任何影響。 In the present invention, an aqueous solution of the hydrolyzed collagen peptide may be used as it is, or it may be powdered by drying or the like. In addition, the aqueous solution can also be used in the form of an aqueous solution or a powder after being subjected to purification treatment for general use. Even if these substances are used in any type, the effect of the present invention will not be affected in any way.
並未特別限制膠原蛋白肽的平均分子量。然而,平均分子量愈大者,愈會降低膠原蛋白肽的體內吸收性,及因 濃度問題在低溫下容易凝固,而平均分子量較小時雖可增大體內吸收性,但卻產生胜肽特有的苦味、澀味等。有鑑於該等問題點,本發明中使用之膠原蛋白肽的平均分子量以300~10,000為佳,500~9,000更佳,500~6,000特佳。另外,該平均分量亦可為1,000~8,700。本說明書中膠原蛋白肽的平均分子量,係意指重量平均分子量,意指利用PAGI法(凝膠過濾管柱色層分析法)之測定值。 The average molecular weight of the collagen peptide is not particularly limited. However, the larger the average molecular weight, the lower the absorption of collagen peptides in vivo, and The concentration problem is easy to coagulate at low temperature, and although the average molecular weight is small, it can increase the absorption in the body, but it produces bitterness and astringency unique to peptides. In view of these problems, the average molecular weight of the collagen peptide used in the present invention is preferably 300 to 10,000, more preferably 500 to 9,000, and particularly preferably 500 to 6,000. In addition, the average component may be 1,000 to 8,700. The average molecular weight of a collagen peptide in this specification means a weight average molecular weight, and means the measured value by a PAGI method (gel filtration column chromatography).
膠原蛋白肽可使用市售品,亦可使用具期望分子量之膠原蛋白肽。例如可使用市售「Nippi Peptide PRA」(Nippi股份有限公司)、「水溶性膠原蛋白肽SS」(協和發酵生物股份有限公司)、「水溶性膠原蛋白肽SCP」(新田明膠股份有限公司)、「HACP」(JELLICE股份有限公司)等。 A commercially available collagen peptide can be used, and a collagen peptide having a desired molecular weight can also be used. For example, commercially available `` Nippi Peptide PRA '' (Nippi Co., Ltd.), `` water-soluble collagen peptide SS '' (Kyowa Fermentation Biology Co., Ltd.), and `` water-soluble collagen peptide SCP '' (Nitta Gelatin Co., Ltd.) , "HACP" (JELLICE Corporation), etc.
本發明中,可單獨使用1種膠原蛋白肽,或可組合使用2種以上膠原蛋白肽。本發明組成物中膠原蛋白肽的總含量,雖可根據含有該膠原蛋白肽組成物之用途而變化,但典型係1.0~35w/v%,較佳係1.0~25w/v%,更佳係2.0~20w/v%。 In the present invention, one type of collagen peptide may be used alone, or two or more types of collagen peptides may be used in combination. Although the total content of the collagen peptide in the composition of the present invention can be changed according to the application containing the collagen peptide composition, it is typically 1.0 ~ 35w / v%, preferably 1.0 ~ 25w / v%, more preferably 2.0 ~ 20w / v%.
蛋白聚醣係指作為核心的蛋白質與軟骨素硫酸鹽(chondroitin sulfate)、硫酸皮膚素(dermatansulfate)等醣胺聚多醣(glycosaminoglycan)(黏多醣)共鍵結合的化合物之總稱。其係存在於動物的軟骨、皮膚等結締組織中,係為 維持該等組織之構造所必需的物質。蛋白聚醣,例如可舉出聚集蛋白聚醣(Aggrecan)、多能蛋白聚醣(Versican)、神經蛋白聚醣(Neurocan)、短小蛋白聚醣(Brevican)、核心蛋白聚醣(Decorin)、雙糖鏈蛋白聚醣(Biglycan)、睾丸蛋白聚醣(Testican)、基底膜聚醣(Perlecan)、營養不良聚醣(Dystroglycan)、集聚蛋白(Agrin)、客林蛋白(Claustrin)等。 Proteoglycan is a general term for compounds in which a core protein is co-bonded with glycosaminoglycan (mucopolysaccharide) such as chondroitin sulfate and dermatansulfate. It is found in connective tissues such as cartilage and skin of animals. Substances necessary to maintain the structure of such organizations. Proteoglycans include, for example, aggrecan (Aggrecan), multipotent proteoglycan (Versican), neuroproteoglycan (Neurocan), short proteoglycan (Brevican), core proteoglycan (Decorin), double Glycan, Testican, Perlecan, Dystroglycan, Agrin, Claustrin, etc.
本發明所使用的蛋白聚醣並未特別限制其種類、來源以及製法。可以單獨使用上述蛋白聚醣之任一種,亦可組合2種以上使用。其中,以聚集蛋白聚醣為佳,可將其單獨使用或與其他蛋白聚醣組合使用。此外,亦未限制蛋白聚醣的來源動物,例如可使用源自哺乳類(牛、豬等)、鳥類(雞等)、魚類(鯊魚、鮭魚等)、軟體動物(烏賊、章魚等)等動物者,進而可使用源自於1種或2種以上的動物者。其中,較佳係源自鮭魚,特別係源自鮭魚的鼻軟骨者,可單獨使用或與其他蛋白聚醣組合使用。相關製造方法,若為採用以水、酸(乙酸等)、鹼(氫氧化鈉、氫氧化鉀等)、醇等溶劑之萃取法等周知之任意方法均可。純化並非必須,但為了進行純化可使用脫鹽、分子量分畫等周知之方法。蛋白聚醣的分子量通常為數萬~數千萬。並未特別限制本發明中使用的蛋白聚醣的分子量,較佳係10萬~200萬。 The proteoglycan used in the present invention is not particularly limited in its kind, source, and production method. Any one of the aforementioned proteoglycans may be used alone, or two or more of them may be used in combination. Among them, aggrecan is preferred, and it can be used alone or in combination with other proteoglycans. In addition, the source animal of proteoglycan is not limited. For example, animals derived from mammals (bovine, pig, etc.), birds (chicken, etc.), fish (shark, salmon, etc.), molluscs (squid, octopus, etc.) can be used. In addition, those derived from one or more animals can be used. Among them, those derived from salmon, particularly from nasal cartilage derived from salmon, can be used alone or in combination with other proteoglycans. The production method may be any known method such as an extraction method using a solvent such as water, acid (acetic acid, etc.), alkali (sodium hydroxide, potassium hydroxide, etc.), or alcohol. Purification is not necessary, but known methods such as desalting and molecular weight division can be used for purification. The molecular weight of proteoglycan is usually tens to tens of millions. The molecular weight of the proteoglycan used in the present invention is not particularly limited, but is preferably 100,000 to 2 million.
本發明中,可直接使用含有蛋白聚醣水溶液,亦可使用經乾燥等粉末化者。另外,亦可將一般使用於相關水溶 液中經施以純化處理者,以水溶液及粉末等型態使用。即使在使用該等物質任一種型態的情況下,亦不會對本發明的效果造成任何影響。 In the present invention, an aqueous solution containing proteoglycan may be used as it is, or powdered by drying or the like may be used. In addition, it can also be used in related water-soluble Those who are subjected to purification treatment in the liquid are used in the form of an aqueous solution or a powder. Even if any of these types of substances is used, the effect of the present invention will not be affected in any way.
本發明組成物中蛋白聚醣的總含量,雖可依據含有組成物的用途而變化,但典型係0.0001~0.05w/v%,較佳係0.001~0.05w/v%,更佳係0.002~0.02w/v%。 Although the total content of proteoglycan in the composition of the present invention may vary depending on the use of the composition, the typical content is 0.0001 to 0.05 w / v%, preferably 0.001 to 0.05 w / v%, and more preferably 0.002 to 0.02w / v%.
含量的測定方法可使用周知之任意方法,例如可使用凝膠色層分析分子量分畫法。亦即使用凝膠色層分析儀進行分子量分畫,再根據蛋白聚醣標準試劑(蛋白聚醣,源自鮭魚鼻軟骨(和光純藥))進行定量,或者測定分子量為1萬以上且已確認存在酸性糖及蛋白質的畫分之乾燥物。此外,酸性糖的存在可使用咔唑硫酸法確認,蛋白質的存在可利用280nm附近處的吸光度測定進行確認。 As a method for measuring the content, any known method can be used, and for example, a gel chromatography method can be used to analyze molecular weight. That is, the molecular weight separation is performed using a gel chromatography analyzer, and then quantified according to a standard proteoglycan reagent (proteoglycan, derived from salmon nasal cartilage (Wako Pure Chemical Industries, Ltd.)), or the molecular weight of 10,000 or more is confirmed The presence of acidic sugars and proteins as a dry product. The presence of acidic sugars can be confirmed using the carbazole sulfuric acid method, and the presence of proteins can be confirmed using absorbance measurements near 280 nm.
神經醯胺係神經胺醇與脂質經由醯胺結合後之神經脂質之一種。神經醯胺與各式各樣的親水性基結合後,形成主要的複合神經脂質(分子中含有磷、硫磺、胺基酸、糖等之神經脂質)。例如,已知神經醯胺與磷酸膽鹼結合後形成的神經磷脂,係動物主要的神經磷脂質。另外,神經醯胺與糖類以醣苷鍵結結合後之物質係神經糖脂質。神經糖脂質廣泛存在於動物、植物、真菌等之中,具代表性者係神經醯胺與單糖結合後之腦糖苷。腦糖苷在動物係以神經醯胺與葡萄糖結合後之葡萄糖神經醯胺,以及神經醯胺 與半乳糖結合後之半乳糖神經醯胺而存在,植物及真菌係以神經醯胺與葡萄糖經由β-醣苷鍵結合後之β-葡萄糖神經醯胺而存在。 Neuraminamine is a type of neurolipid in which neuraminol is combined with lipids through amidine. Neuramin is combined with various hydrophilic groups to form the main complex neurolipids (neurolipids containing phosphorus, sulfur, amino acids, sugars, etc. in the molecule). For example, it is known that the neurophospholipid formed by the combination of neuraminamide and choline phosphate is the main neurophospholipid of animals. In addition, the substance in which neuraminamine and sugar are bound by a glycoside is a neuroglycolipid. Neuroglycolipids are widely found in animals, plants, fungi, etc. A typical example is the brain glycosides after the combination of neural amines and monosaccharides. Cerebral glycosylceramide and ceramide in animals Galactosylceramide is combined with galactose, and plants and fungi are β-glucosylceramide, which is combined with neuraminamine and glucose via β-glycosidic bonds.
神經醯胺存在於皮膚最外層的角質層中,在皮膚保溼功能與屏障功能方面扮演重要的角色。另外,已知神經醯胺由表皮細胞中產生及分泌後,藉由構築角質層中細胞間的網狀構造而發揮皮膚的保溼效果,且具有皮膚的保護作用與防止肌膚粗糙乾燥之效果。 Nervamine exists in the stratum corneum, the outermost layer of the skin, and plays an important role in skin moisturizing and barrier functions. In addition, it is known that neural crestamine is produced and secreted from epidermal cells and exerts a moisturizing effect on the skin by constructing a reticular structure between cells in the stratum corneum, and has the effect of protecting the skin and preventing rough and dry skin.
使用於本發明之神經醯胺若為具有神經磷脂骨骼之化合物則無特別限制,可舉出例如神經醯胺、糖神經醯胺、神經磷脂質、神經糖脂質等、特別以糖醯胺為佳。糖醯胺可舉出葡萄糖神經醯胺、半乳糖神經醯胺等,特別以葡萄糖醯胺為佳。市售品可使用例如市售之OrizaseramidoWSP(ORIZA油化股份有限公司)、乳神經醯胺MC-5SD30(雪印惠股份有限公司)等。 The neural crestamine used in the present invention is not particularly limited as long as it is a compound having a neurophospholipid skeleton, and examples thereof include neural crestamine, glycoceramidamine, neurophospholipids, and neuroglycolipid. Particularly preferred is glycogenamine. . Examples of glucosamine include glucosamine, galactosamine and the like, and glucosamine is particularly preferred. As a commercially available product, for example, commercially available Orizaseramido WSP (ORIZA Petrochemical Co., Ltd.), breast nerve melamine MC-5SD30 (Xue Yinhui Co., Ltd.), and the like can be used.
本發明中使用之神經醯胺原料可舉出例如動物方面可來自豬、牛、馬等的表皮、腦、魚類的內臟與頭部、軟體動物與節肢動物、雞蛋、牛奶等,植物方面可舉出例如小麥、黑麥、稻米、黃豆、玉米、黍米、蒟篛、波菜、菌菇類(舞菇、黃金蘑菇等)、葡萄、櫻桃、柚子、橄欖、紫蘇、台灣香檬、李子、甜菜等,但未被限定於該等物質。其中,以來自米者為佳。另外,本發明中使用之神經醯胺可為天然物亦可為合成品,亦未特別限制神經醯胺的萃取及純化方法。雖然可使用含神經醯胺的動植物萃取物,及 利用各種方法提高神經醯胺含有比例之調整物,但並未特別限定神經醯胺的純度,除了施以純化處理具有高純度的神經醯胺之外亦可使用低純度的粗神經醯胺。 Neuraminamine raw materials used in the present invention include, for example, the epidermis of animals, which can be derived from pigs, cattle, horses, etc., the internal organs and heads of fish, fish, molluscs and arthropods, eggs, milk, etc. For example, wheat, rye, rice, soybeans, corn, barley, coriander, lettuce, mushroom (mushroom, golden mushroom, etc.), grape, cherry, grapefruit, olive, perilla, Taiwan lemon, plum, Beets and the like are not limited to these substances. Among them, those from rice are preferred. In addition, the Neuraminamine used in the present invention may be a natural product or a synthetic product, and the method for extracting and purifying Neuraminamine is not particularly limited. Although animal and plant extracts containing ceramide can be used, and Regulating substances for increasing the content of Neuraminamine by various methods, but the purity of Neuraminamine is not particularly limited, and crude Neuraminamine of low purity may be used in addition to purifying Neuraminamine with high purity.
本發明中,可直接使用含神經醯胺的水溶液,亦可使用經乾燥等而粉末化者。另外,可將對該當水溶液經施以一般使用的純化處理後所得者,以水溶液與粉末等型態使用。於使用該等任一種型態者之情況下,均不會對本發明的效果有任何影響。 In the present invention, an aqueous solution containing ceramide may be used directly, or a powder obtained by drying or the like may be used. In addition, the aqueous solution obtained by subjecting the aqueous solution to a general-purpose purification treatment may be used in the form of an aqueous solution or a powder. In the case of using any of these types, the effect of the present invention will not be affected in any way.
本發明水性液體組成物中神經醯胺的總含量,可依含其之組成物的用途而變化,典型係0.0001~0.1w/v%,較佳係0.0005~0.05w/v%,更佳係0.001~0.005w/v%。 The total content of neuraminamine in the aqueous liquid composition of the present invention may vary depending on the use of the composition containing it, typically 0.0001 to 0.1 w / v%, preferably 0.0005 to 0.05 w / v%, and more preferably 0.001 ~ 0.005w / v%.
果膠係高分子碳水化合物,係植物體內作為細胞與細胞間連結成分特別含於植物的葉、莖、果實中。該果膠係D-半乳糖醛酸藉由α-1,4鍵結以直鏈狀結合的聚半乳糖醛酸,係由原果膠質、果膠醋酸、醯胺化果膠、果膠酸等所構成。由於果膠亦可此用於酸性食品,可使用為果醬、果凍等之凝膠化劑,以及優格飲料等乳蛋白質安定劑。 Pectin-based high-molecular-weight carbohydrates are particularly contained in the leaves, stems, and fruits of plants as cells and intercellular connection components in plants. The pectin is D-galacturonic acid, which is a polygalacturonic acid which is linearly bound by α-1,4 bond. And so on. Since pectin can also be used in acidic foods, gelling agents such as jams, jellies, and milk protein stabilizers such as yogurt can be used.
果膠一般大致分為酯化度為50%以上的HM果膠,以及未達50%的LM果膠,雖然各自的凝膠化條件與凝膠化特性相異,但本發明並未特別加以限定。 Pectin is generally divided into HM pectin with an esterification degree of 50% or more, and LM pectin less than 50%. Although the respective gelation conditions and gelation characteristics are different, the present invention does not specifically add limited.
本發明中使用的果膠,可藉由自植物原料中萃取獲得,但未特別限定其來源及製造方法。例如可將柑橘類 (柳橙、葡萄柚、柚子、萊姆、檸檬等)及蘋果、甜菜等作為原料使用。含果膠的部位有葉片、莖、果實、果皮等,本發明中使用的部位並未特別限制,可以是果實全體等,也可以選用特定部位。另外,並未特別限定品種。本發明中,較佳係可使用來自柑橘類果皮的果膠。可使用例如市售果膠P-27(新田明膠股份有限公司)、NeosofutoP(太陽化學股份有限公司)等。本發明中可使用的果膠並未特別限制其製造方法,可使用周知的方法,自植物等原料可經萃取、過濾、酒精沉澱、乾燥、粉碎等步驟進行製造。 The pectin used in the present invention can be obtained by extraction from plant raw materials, but its source and manufacturing method are not particularly limited. For example, citrus (Orange, grapefruit, grapefruit, lime, lemon, etc.) and apples, beets, etc. are used as raw materials. The parts containing pectin include leaves, stems, fruits, peels, and the like. The parts used in the present invention are not particularly limited, and may be whole fruits, etc., or specific parts may be selected. The variety is not particularly limited. In the present invention, pectin derived from a citrus peel is preferably used. For example, commercially available pectin P-27 (Nitta Gelatin Co., Ltd.), NeosofutoP (Sun Chemical Co., Ltd.), and the like can be used. The production method of pectin that can be used in the present invention is not particularly limited, and a well-known method can be used. Raw materials such as plants can be produced through extraction, filtration, alcohol precipitation, drying, and pulverization.
本發明中,可直接使用含果膠的水溶液,亦可使用經乾燥等而粉末化者。另外,可將對該當水溶液經施以一般使用的純化處理後所得者,以水溶液與粉末等型態使用。於使用該等任一種型態者之情況下,均不會對本發明的效果有任何影響。 In the present invention, an aqueous solution containing pectin may be used directly, or a powder obtained by drying or the like may be used. In addition, the aqueous solution obtained by subjecting the aqueous solution to a general-purpose purification treatment may be used in the form of an aqueous solution or a powder. In the case of using any of these types, the effect of the present invention will not be affected in any way.
本發明組成物中果膠的總含量,可依含其之組成物的用途而變化,典型係0.05~0.8w/v%,較佳係0.05~0.5w/v%,更佳係0.1~0.5w/v%,進而更佳為0.1~0.3w/v%。 The total content of pectin in the composition of the present invention may vary depending on the use of the composition containing it, typically 0.05 to 0.8 w / v%, preferably 0.05 to 0.5 w / v%, and more preferably 0.1 to 0.5 w / v%, more preferably 0.1 to 0.3 w / v%.
本發明為了抑制來自組成物中之膠原蛋白肽、蛋白聚糖及神經醯胺之凝集物或沉澱物之生成,係摻混果膠。並未特別限制本發明中蛋白聚糖重量與果膠重量的比率,例如,相關組成物中蛋白聚糖重量與果膠重量的比率(蛋白 聚糖重量:果膠重量)係1:1以上,較佳係1:2以上,更佳為1:5以上,再者更佳為1:10以上,1:800以下,較佳係1:500以下,更佳為1:100以下,進而更佳為1:50以下。具體而言,相關組成物中蛋白聚糖重量與果膠重量的比率(蛋白聚糖重量:果膠重量)係1:1~1:800,較佳係1:2~1:500,更佳為1:5~1:100,進而更佳為1:10~1:50。 In the present invention, pectin is blended in order to inhibit the formation of aggregates or precipitates of collagen peptides, proteoglycans, and neuraminamine from the composition. The ratio of the weight of proteoglycan to the weight of pectin in the present invention is not particularly limited, for example, the ratio of the weight of proteoglycan to the weight of pectin in the related composition (protein Glycan weight: pectin weight) is 1: 1 or more, preferably 1: 2 or more, more preferably 1: 5 or more, more preferably 1:10 or more, 1: 800 or less, preferably 1: 500 or less, more preferably 1: 100 or less, and even more preferably 1:50 or less. Specifically, the ratio of proteoglycan weight to pectin weight (proteoglycan weight: pectin weight) in the related composition is 1: 1 to 1: 800, preferably 1: 2 to 1: 500, and more preferably It is 1: 5 to 1: 100, and more preferably 1:10 to 1:50.
起因於膠原蛋白肽、蛋白聚糖及神經醯胺之凝集物或沉澱物之生成,大多在低pH範圍時造成問題。利用本發明之含有膠原蛋白肽、蛋白聚糖、神經醯胺及果膠之組成物,亦可抑制在低pH範圍時前述之凝集物與沉澱物之生成。並未特別限定本發明組成物之pH,但有鑑於上述特性,以低pH為佳。該等低pH範圍典型係pH2.5~pH5.0,較佳係pH3.0~pH4.5,更佳係pH3.3~pH4.0。另外,其他實施方式為pH2.5~pH3.4,較佳係pH2.8~pH3.2,更佳係pH3.6~pH5.0,最佳係pH3.8~pH4.5。 Caused by the formation of aggregates or precipitates of collagen peptides, proteoglycans, and ceramides, most of them cause problems in the low pH range. By using the composition containing collagen peptide, proteoglycan, neuraminil and pectin of the present invention, the formation of the aforementioned aggregates and precipitates can also be suppressed at a low pH range. The pH of the composition of the present invention is not particularly limited, but in view of the above characteristics, a low pH is preferred. These low pH ranges typically range from pH 2.5 to pH 5.0, preferably pH 3.0 to pH 4.5, and more preferably pH 3.3 to pH 4.0. In addition, other embodiments are pH 2.5 to pH 3.4, preferably pH 2.8 to pH 3.2, more preferably pH 3.6 to pH 5.0, and most preferably pH 3.8 to pH 4.5.
本發明係有關含有膠原蛋白肽、蛋白聚糖、神經醯胺及果膠之組成物。本說明書中「組成物」並無特別限制。例如可舉出固體組成物與液體組成物等。較佳係以水為基 底的液狀組成物,更佳係水性液狀組成物,例如可舉出水溶液、懸濁液、分散液等。一般而言,含膠原蛋白的水溶液於保存中有時會產生沉澱或分離,使用時加以震盪使該沉澱物或分離物分散或溶解。因此,本發明之組成物中亦包含產生如該等可容許程度之沉澱、分離、白濁等者。另外,該組成物中,亦可因應需要含有酒精等水以外的媒質。 The present invention relates to a composition containing collagen peptide, proteoglycan, neuraminamine and pectin. The "composition" in this specification is not particularly limited. Examples thereof include a solid composition and a liquid composition. Water based The liquid composition at the bottom is more preferably an aqueous liquid composition, and examples thereof include an aqueous solution, a suspension, and a dispersion. Generally, a collagen-containing aqueous solution sometimes precipitates or separates during storage, and when used, it is shaken to disperse or dissolve the precipitate or isolate. Therefore, the composition of the present invention also includes those that produce such permissible levels of precipitation, separation, white turbidity, and the like. Moreover, this composition may contain media other than water, such as alcohol, as needed.
本發明組成物可因應目的進而含有植物素材。該植物素材以含有具美容效果成分者為佳,例如可舉出楜椒科植物萃取物(例如蓽菝萃取物)、亞麻木脂素(亞麻木脂素、羅漢松樹脂酚、松脂醇、異落葉松脂素等)、亞麻仁萃取物、櫻花萃取物、藍錠果萃取物、生薑萃取物、桂皮萃取物、大豆異黃酮、玫瑰花萃取物、源自植物(小麥、米胚芽、蒟篛、玉米胚芽、鳳梨)神經醯胺、荷花胚芽萃取物、甜茶萃取物、火棘萃取物、松樹皮萃取物、瑪卡萃取物、洋薊葉萃取物、香茶菜萃取物、小連翹萃取物、鼠尾草萃取物、菩提樹萃取物、羅漢果萃取物、魚腥草萃取物、印度楝葉萃取物、積雪草萃取物、餘甘子萃取物、山竹果皮萃取物、花楸果萃取物、杜仲葉萃取物、薏苡仁萃取物、高麗參萃取物、果實種子萃取物、紫米萃取物、月桃葉萃取物、楊桃葉萃取物、蘆薈萃取物等,可將該等植物中的1種或2種以上使用為本發明組成物成分。 The composition of the present invention may further contain plant material according to the purpose. The botanical material preferably contains a component having a cosmetic effect. Examples of the botanical material include a plant extract of the family Capsicum annuum (e.g., amaranth extract), and a linolin (linolin lignan, mogropine resin phenol, pinoresinol, isopropyl alcohol) Larch, etc.), linseed extract, cherry blossom extract, blueberry extract, ginger extract, cinnamon extract, soy isoflavones, rose extract, plant-derived (wheat, rice germ, loquat , Corn germ, pineapple) Neuraminamine, lotus germ extract, sweet tea extract, pyracantha extract, pine bark extract, maca extract, artichoke leaf extract, fragrant tea vegetable extract, forsythia extract , Sage extract, linden extract, mogro extract, houttuynia cordata extract, neem leaf extract, centella asiatica extract, licorice extract, mangosteen peel extract, rowan fruit extract, eucommia leaf Extract, Coix Seed Extract, Korean Ginseng Extract, Fruit Seed Extract, Purple Rice Extract, Moon Peach Leaf Extract, Star Fruit Leaf Extract, Aloe Vera Extract, etc. One or two of these plants can be used The above makes Component of a composition of the present invention.
蓽菝萃取物、亞麻仁萃取物、櫻花萃取物、藍錠果萃取物,分別可自蓽菝(Piper longum)的果穗、亞麻仁或亞麻仁粕、櫻花、忍冬科藍錠果(Lonicera caerulea L.ssp.edulis Hulten)的果實藉由壓榨、溶劑萃取等方法製得之榨汁與萃取液,再進行濃縮而得。其他萃取物亦可同樣地從植物原料製得。萃取時可使用水、甲醇、乙醇、異丙醇等溶劑。此外,雖非必須但有時也會進行純化。 Coriander extract, linseed extract, cherry blossom extract, and blue fruit extract can be obtained from the ears of Piper longum, linseed or linseed meal, cherry blossom, and blueberry fruit (Lonicera caerulea L .ssp.edulis Hulten) fruit juice and extracts obtained by pressing, solvent extraction and other methods, and then concentrated. Other extracts can be similarly prepared from plant materials. For extraction, solvents such as water, methanol, ethanol, and isopropanol can be used. In addition, although not necessary, purification is sometimes performed.
於不對本發明效果造成不良影響之情況下,本發明組成物中可進而含有追加的成分。該等成分例如維他命類、礦物質類、營養成分、香料、抗氧化劑、色素類、保存料、調味料、甜味料、酸味料、pH調整劑、安定劑、等張化劑、乳化劑、緩衝劑、營養強化劑、防腐劑。 Without adversely affecting the effects of the present invention, the composition of the present invention may further contain additional components. These ingredients include, for example, vitamins, minerals, nutritional ingredients, flavors, antioxidants, pigments, preservatives, seasonings, sweeteners, sour agents, pH adjusters, stabilizers, isotonicity agents, emulsifiers, Buffer, nutrition fortifier, preservative.
由於本發明之組成物可期待來自膠原蛋白肽等成分的優良的美膚效果,可提供其要旨具明示或暗示可使用例如為了防止肌膚粗糙乾燥、保護皮膚、改善肌膚鬆弛等之組成物,對於乾燥肌膚、肌膚粗糙、肌膚鬆弛等對象而言極為有效。 Since the composition of the present invention is expected to have excellent skin-beautifying effects derived from ingredients such as collagen peptides, it is possible to provide a composition expressly or implying that the composition can be used, for example, to prevent rough and dry skin, protect the skin, and improve skin relaxation. It is extremely effective for dry skin, rough skin, and saggy skin.
本發明之組成物可提供為食品、醫藥品及化妝料等型態。將本發明組成物提供為食品時,其型態可提供為功能性食品、營養補充品、飲料劑(含溶液劑及懸濁劑)等健康 食品之型態,亦可提供為清涼飲料、茶飲料、乳酸菌飲料等型態。但未被限定於這些型態。 The composition of the present invention can be provided in the form of food, pharmaceuticals, and cosmetics. When the composition of the present invention is provided as a food, its form can be provided as a functional food, a nutritional supplement, a beverage (including a solution and a suspension agent) and other health Food types can also be provided as refreshing beverages, tea beverages, lactic acid bacteria beverages and other types. It is not limited to these types.
本發明組成物可製成容器包裝。容器型態並無任何限制,可填充於瓶、罐、紙盒、寶特瓶、鋁箔包、塑膠包或吹出成型容器等密封容器內而得。 The composition of the present invention can be made into a container and a package. There are no restrictions on the type of container. It can be filled in sealed containers such as bottles, cans, cartons, PET bottles, aluminum foil bags, plastic bags, or blow-molded containers.
該容器上可附註標示。相關標示內容,可附註具有起因於膠原蛋白肽、蛋白聚糖、神經醯胺或果膠的效能之表示。例如保溼用、保護皮膚用、防止肌膚乾燥用、改善肌膚鬆弛用等用途。該等標示可附註於組成物本身,亦可附在組成物的容器或包裝上。 The container can be marked with notes. Relevant labeling content can be supplemented by indications of the efficacy due to collagen peptides, proteoglycans, neuraminidase or pectin. For example, moisturizing, protecting the skin, preventing dryness of the skin, and improving skin relaxation. These labels may be attached to the composition itself or attached to the container or packaging of the composition.
本發明之飲料若為使用含有膠原蛋白肽、蛋白聚糖、神經醯胺及果膠之組成物而製造者則無特別限制,可遵循常法製造。亦即,將含有膠原蛋白肽、蛋白聚糖、神經醯胺及果膠之組成物作為原料,於該組成物中調和酸味料、甜味料等,再經由殺菌、填充步驟等而製造。殺菌條件若為滿足食品衛生法規定的條件即可,可使用加熱板式熱交換器、管式熱交換器、瞬間殺菌器等各種殺菌機。另外,亦未特別限制填充方法,可採用熱袋填充與無菌填充等。 The beverage of the present invention is not particularly limited as long as it is produced by using a composition containing collagen peptide, proteoglycan, ceramide, and pectin, and can be produced according to a conventional method. That is, a composition containing a collagen peptide, proteoglycan, neuraminamine, and pectin is used as a raw material, and a sour flavor, a sweetener, and the like are blended in the composition, and then manufactured through sterilization and filling steps. As long as the sterilization conditions satisfy the conditions prescribed by the Food Sanitation Law, various sterilizers such as a heating plate heat exchanger, a tube heat exchanger, and an instant sterilizer can be used. In addition, the filling method is not particularly limited, and hot bag filling and aseptic filling can be used.
本發明亦有關含有膠原蛋白肽、蛋白聚糖及神經醯胺之組成物中,抑制凝集物或沉澱物生成之方法。該方法之特徵係於該組成物中摻混果膠。並未特別限制該組成物中果膠的總含量,典型係0.05~0.8w/v%,較佳係0.05~ 0.5w/v%,更佳係0.1~0.5w/v%,進而更佳為0.1~0.3w/v%。另外,並未特別限制該組成物中蛋白聚糖重量與果膠重量的比率(蛋白聚糖重量:果膠重量),典型係1:1以上,較佳係1:2以上,更佳為1:5以上,再者更佳為1:10以上,1:800以下,較佳係1:500以下,更佳為1:100以下,進而更佳為1:50以下。具體而言,相關組成物中蛋白聚糖重量與果膠重量的比率(蛋白聚糖重量:果膠重量)係1:1~1:800,較佳係1:2~1:500,更佳為1:5~1:100,進而更佳為1:10~1:50,但並未被限定於此。 The invention also relates to a method for inhibiting the formation of agglutinates or precipitates in a composition containing collagen peptides, proteoglycans, and neuraminamine. This method is characterized by blending pectin into the composition. There is no particular limitation on the total content of pectin in the composition, typically 0.05 to 0.8 w / v%, and more preferably 0.05 to 0.5w / v%, more preferably 0.1 ~ 0.5w / v%, and even more preferably 0.1 ~ 0.3w / v%. In addition, the ratio of proteoglycan weight to pectin weight (proteoglycan weight: pectin weight) in the composition is not particularly limited, and is typically 1: 1 or more, preferably 1: 2 or more, and more preferably 1 : 5 or more, more preferably 1: 10 or more, 1: 800 or less, more preferably 1: 500 or less, more preferably 1: 100 or less, and even more preferably 1: 50 or less. Specifically, the ratio of proteoglycan weight to pectin weight (proteoglycan weight: pectin weight) in the related composition is 1: 1 to 1: 800, preferably 1: 2 to 1: 500, and more preferably It is 1: 5 to 1: 100, and more preferably 1:10 to 1:50, but it is not limited to this.
將果膠摻混於該組成物中之方法及時機並未特別限制,該組成物中最終含有果膠即可。例如可於含果膠之組成物中添加或混合其他成分,亦可於含有其他成分之組成物中添加或混合果膠。 The method and timing for blending pectin into the composition is not particularly limited, and the composition may contain pectin at the end. For example, other components may be added or mixed in the composition containing pectin, and pectin may also be added or mixed in the composition containing other components.
以下,藉實施例更具體說明本發明,但本發明不限於此。 Hereinafter, the present invention will be described more specifically with reference to examples, but the present invention is not limited thereto.
為評價含有膠原蛋白肽、蛋白聚醣、神經醯胺及果膠之組成物,香味及經時性發生的沉澱及沉澱物凝集的抑制效果,製造表1所示摻混之2種飲料。 In order to evaluate the composition containing collagen peptides, proteoglycans, ceramides, and pectins, and the effect of suppressing the scent and precipitation over time and the aggregation of the precipitates, two kinds of beverages as shown in Table 1 were produced.
具體而言,係將酸味料以外的原料加入水中溶解,再 以酸味料將pH調節為3.50±0.20後,添加至容器容量。pH調節等所需的酸味料的最終摻混量示於表1。所得溶液以加熱板式熱交換器殺菌後,每50mL分裝於褐色瓶中並封蓋後,製得飲料(1)及(2)。使用的膠原蛋白肽的平均分子量為3,000,蛋白聚醣係源自於鮭魚鼻軟骨,分子量約45萬,神經醯胺係來自米之葡萄糖神經醯胺,植物萃取物為蓽菝萃取物,果膠係來自柑橘果皮之HM果膠。 Specifically, raw materials other than sour ingredients are dissolved in water, and then After adjusting the pH to 3.50 ± 0.20 with a sour material, it was added to the container capacity. Table 1 shows the final blending amounts of the sour ingredients required for pH adjustment and the like. After the obtained solution was sterilized by a heating plate heat exchanger, each 50 mL was dispensed in a brown bottle and capped, and beverages (1) and (2) were prepared. The average molecular weight of the collagen peptide used is 3,000. The proteoglycan is derived from salmon nasal cartilage and has a molecular weight of about 450,000. The neural peptamine is derived from gluconeuramin of rice. The plant extract is peptone and pectin HM pectin from citrus peel.
將該等飲料於5℃下保存4個月,然後以目視及3位專門測試員針對沉澱量、沉澱物的性狀以及香味進行官能試驗。 The beverages were stored at 5 ° C for 4 months, and then a visual test and 3 special testers were used to perform a functional test on the amount of precipitate, the properties of the precipitate, and the flavor.
摻混量與評價結果共同示於表1。此外,評價標準示於表2。 The blending amount and evaluation results are shown in Table 1. The evaluation criteria are shown in Table 2.
【表2】 【Table 2】
-:無沉澱物 -: No sediment
±:可略微確認沉澱物 ±: Slightly confirmed sediment
+※:可確認少量沉澱物 + ※: A small amount of precipitate can be confirmed
+:可確認沉澱物 +: The precipitate can be confirmed
+*:可確認多量沉澱物 + *: A large amount of precipitate can be confirmed
++:可顯著確認沉澱物 ++: Significant confirmation of precipitates
◎:不震盪也分散 ◎: Dispersion without shaking
○:輕微震盪即分散 ○: Slightly oscillated and dispersed
△:強烈震盪即分散 △: Strong shock is dispersed
×:強烈震盪也不分散 ×: Strong shock and no dispersion
5:理想的香味與食感 5: Ideal scent and texture
4:幾乎感覺不到不愉快的香味與食感 4: Unpleasantly unpleasant flavor and texture
3:感覺到稍微不愉快的香味與食感 3: Slightly unpleasant scent and texture
2:感覺到不愉快的香味與食感 2: Feeling unpleasant fragrance and food texture
1:感覺到非常不愉快的香味與食感 1: Feeling very unpleasant scent and texture
*平均點數4.5~5.0記做◎,4.0~4.4記做○,3.0~3.9記做△,未達3.0記做×。 * Average points 4.5 to 5.0 are marked as ◎, 4.0 to 4.4 are marked as ○, 3.0 to 3.9 are marked as △, and less than 3.0 are marked as ×.
未添加果膠的飲料(1)沉澱量多,且沉澱物的凝集性強而不易分散。反之,添加果膠的(2),顯示維持良好的香味亦抑制了沉澱量,且沉澱物的凝集性弱而易於分散。 The beverage (1) without added pectin has a large amount of precipitation, and the agglutination of the precipitate is strong and it is not easy to disperse. Conversely, (2) with the addition of pectin showed that maintaining a good flavor also suppressed the amount of precipitation, and the agglutination of the precipitate was weak and easily dispersed.
為評價含有膠原蛋白肽、蛋白聚醣、神經醯胺及增黏安定劑之組成物,香味及經時性發生的沉澱及沉澱物凝集的抑制效果,製造表3所示摻混之飲料。 In order to evaluate the composition containing collagen peptides, proteoglycans, neuraminamine, and viscosity-increasing stabilizers, flavor and aging-preventive precipitation inhibition effects, and the blended beverages shown in Table 3 were produced.
具體而言,係將酸味料以外的原料加入水中溶解,再以酸味料將pH調節為3.50±0.20後,再將體積增至1000ml。pH調節等所需的酸味料的最終摻混量示於表3。所得溶液每50mL分裝於褐色瓶中並封蓋後,以浸漬進行殺菌後,製得飲料(3)及(16)。且,使用的膠原蛋白肽、蛋白聚醣、神經醯胺、植物萃取物及果膠係與實施例1相同。將該等飲料於5℃下保存4天,然後以目視及3位專門測試員針對沉澱量、沉澱物的性狀以及香味、食感進行官能試驗。 Specifically, raw materials other than the sour material are added to the water to dissolve, the pH is adjusted to 3.50 ± 0.20 with the sour material, and then the volume is increased to 1000 ml. Table 3 shows the final blending amounts of the sour ingredients required for pH adjustment and the like. The obtained solution was dispensed into a brown bottle every 50 mL, sealed, and sterilized by dipping, and beverages (3) and (16) were prepared. The collagen peptide, proteoglycan, neuraminine, plant extract, and pectin used were the same as in Example 1. The beverages were stored at 5 ° C for 4 days, and then a visual test and 3 special testers were used to perform a functional test on the amount of precipitate, the properties of the precipitate, the flavor, and the texture.
評價結果示於表4。此外,評價標準係如表2所載。 The evaluation results are shown in Table 4. In addition, the evaluation criteria are as shown in Table 2.
添加果膠的飲料(4)及(5),顯示沉澱的生成顯著地被抑制,且沉澱物的凝集性弱而易於分散,進而具有良好的香味與食感。 The beverages (4) and (5) to which pectin was added showed that the generation of precipitation was significantly suppressed, and the agglutination of the precipitate was weak and easy to disperse, thereby having good flavor and food texture.
為評價蛋白聚醣及果膠的添加量,對香味、食感及經時性發生的沉澱及沉澱物凝集造成的影響,利用與實施例2相同的方法,製造表5所示摻混之(17)~(26)之飲料。 In order to evaluate the effects of the addition amount of proteoglycan and pectin on the aroma, food texture, and the precipitation and coagulation of precipitates over time, the same method as in Example 2 was used to produce the blended compounds shown in Table 5 ( 17) ~ (26).
將該等飲料於5℃下保存8天,然後以目視及3位專門測試員針對沉澱量、沉澱物的性狀以及香味進行官能試驗,在第4天及第8天進行評價。 The beverages were stored at 5 ° C for 8 days, and then the visual test and 3 special testers were used to perform a functional test on the amount of sediment, the properties and flavor of the precipitate, and the evaluation was performed on the 4th and 8th days.
評價結果示於表6。此外,評價標準係如表2所載。 The evaluation results are shown in Table 6. In addition, the evaluation criteria are as shown in Table 2.
以0.001w/v%的濃度添加蛋白聚糖時,藉由以0.05w/v%的濃度添加果膠,可大幅抑制沉澱形成。另外,以0.01w/v%的濃度添加蛋白聚糖時,發現以0.05w/v%的濃度添加果膠,可抑制沉澱形成,藉由以1.0w/v%的添加濃度,可顯著抑制沉澱形成。進而,以0.05w/v%的濃度添加蛋白聚糖時,發現隨著果膠添加濃度之增加,有抑制沉澱形成之傾向。而針對香味、食感,以1.0w/v%濃度添加果膠時,黏度變高,欠缺香味的釋出,且食感變重。 When proteoglycan is added at a concentration of 0.001 w / v%, by adding pectin at a concentration of 0.05 w / v%, the formation of precipitates can be significantly suppressed. In addition, when proteoglycan was added at a concentration of 0.01 w / v%, it was found that the addition of pectin at a concentration of 0.05 w / v% can suppress the formation of precipitates, and by adding a concentration of 1.0 w / v%, precipitation can be significantly suppressed. form. Furthermore, when proteoglycan was added at a concentration of 0.05 w / v%, it was found that as the concentration of pectin added was increased, the formation of precipitates tended to be suppressed. For flavor and food texture, when adding pectin at a concentration of 1.0 w / v%, the viscosity becomes higher, the flavor is not released, and the food texture becomes heavy.
利用與實施例2相同的方法,製造表7所示摻混之(27)及(28)之飲料。 In the same manner as in Example 2, the beverages (27) and (28) blended as shown in Table 7 were produced.
確認未添加果膠的飲料(27)有沉澱的生成。反之,經添加果膠的飲料(28)顯示沉澱的生成顯著地被抑制,且沉澱物的凝集性弱而易於分散,進而具有良好的香味與食感。 It was confirmed that the beverage (27) without added pectin had precipitated. On the contrary, the beverage (28) added with pectin showed that the generation of precipitation was significantly suppressed, and the agglutination of the precipitate was weak and easy to disperse, thereby having good flavor and food texture.
本發明係藉由於含有膠原蛋白肽、蛋白聚糖及神經醯胺之組成物中摻混果膠,可抑制凝集物或沉澱物的生成。由於果膠係來自天然成分具有高安全性。因此,本發明係藉由簡便且安全之方法,可使含有膠原蛋白肽組成物之外觀維持於良好的狀態,在產業上具有高利用性。 The present invention suppresses the formation of agglutinates or precipitates by blending pectin in a composition containing collagen peptides, proteoglycans, and neuraminamine. Because pectin is derived from natural ingredients, it has high safety. Therefore, the present invention can maintain the appearance of the collagen peptide-containing composition in a good state by a simple and safe method, and has high industrial applicability.
Claims (9)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW105101036A TWI676485B (en) | 2016-01-12 | 2016-01-12 | Composition containing collagen peptide |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW105101036A TWI676485B (en) | 2016-01-12 | 2016-01-12 | Composition containing collagen peptide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW201725031A TW201725031A (en) | 2017-07-16 |
| TWI676485B true TWI676485B (en) | 2019-11-11 |
Family
ID=60047302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW105101036A TWI676485B (en) | 2016-01-12 | 2016-01-12 | Composition containing collagen peptide |
Country Status (1)
| Country | Link |
|---|---|
| TW (1) | TWI676485B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113875993B (en) * | 2021-12-07 | 2022-04-01 | 北京中科生仪科技有限公司 | Composition for resisting wrinkles, moisturizing and improving skin elasticity and preparation process thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002027957A (en) * | 2000-07-17 | 2002-01-29 | Mitsui Norin Co Ltd | Plant polyphenol-containing liquid composition |
| WO2015156246A1 (en) * | 2014-04-10 | 2015-10-15 | サントリーホールディングス株式会社 | Method for masking bitterness of composition containing collagen peptide |
-
2016
- 2016-01-12 TW TW105101036A patent/TWI676485B/en active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002027957A (en) * | 2000-07-17 | 2002-01-29 | Mitsui Norin Co Ltd | Plant polyphenol-containing liquid composition |
| WO2015156246A1 (en) * | 2014-04-10 | 2015-10-15 | サントリーホールディングス株式会社 | Method for masking bitterness of composition containing collagen peptide |
Also Published As
| Publication number | Publication date |
|---|---|
| TW201725031A (en) | 2017-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI656885B (en) | Aqueous liquid composition containing collagen | |
| JP6530187B2 (en) | Collagen peptide-containing composition | |
| CN106170213B (en) | Bitterness masking method containing collagen peptide composition | |
| JP6608874B2 (en) | Beauty composition | |
| JP3495712B2 (en) | Food composition | |
| JP2023532093A (en) | Plant extract containing plant collagen and plant mucin, and method for producing the same | |
| HK1206561A1 (en) | Skin condition amelioration agent | |
| TWI676485B (en) | Composition containing collagen peptide | |
| JP6753618B2 (en) | Composition for suppressing increase in triglyceride in blood | |
| JP6317288B2 (en) | Beverage composition | |
| JP2020186264A (en) | In-blood neutral fat increase inhibitory composition | |
| CN108697614B (en) | Composition containing collagen peptides | |
| JP6744673B2 (en) | Joint function improving composition | |
| JP6841444B2 (en) | Immunostimulant | |
| JP2022079610A (en) | Composition for suppressing increase in triglyceride in blood | |
| HK1256943B (en) | Collagen peptide-containing composition | |
| Almoselhy et al. | New aspects on nutraceutical formulations of whey protein concentrate sweetened with steviol glycosides for patients with non-communicable diseases | |
| JP6211558B2 (en) | Beauty composition | |
| JP2015140325A (en) | Collagenase inhibitor, and cosmetic composition and functional food containing collagenase inhibitor | |
| JP5725663B2 (en) | Enzyme inhibitor | |
| JP2014009198A (en) | Hyaluronidase activity inhibitor composition | |
| JP2024019607A (en) | beauty composition | |
| JP2019218411A (en) | Cosmetic composition | |
| KR20250048190A (en) | Parsnip-Derived Skin Elasticity & Antioxidant Inner Beauty Drink and Manufacturing Method Thereof | |
| BR102022018204A2 (en) | MICROENCAPSULATION OF ORANGE JUICE (CITRUS SINENSIS) AND HYDROLYZED COLLAGEN BY IONIC GELIFICATION |